Open Access
Subscription Access
Open Access
Subscription Access
Oral Contraceptive Pills:Benefits Beyond Contraception
Subscribe/Renew Journal
Amongst the events that changed the history of the world was the landmark discovery in 1956 by Rock, Garcia and Pincus that fertility control in women can be achieved by suppressing ovulation by a combination of progestational and estrogenic agents. Over the decades, considerable changes have occurred in the formulation of the combined oral contraceptive pill (COCs) to its latest low-dose version today. While the primary indication for COCs use is prevention of pregnancy, the healthcare provider must counsel women about the non-contraceptive benefits when contraception is discussed and prescribed.
Subscription
Login to verify subscription
User
Font Size
Information
- NHFS 4 (National Family Health Survey) 2015-16, Ministry of Health and Family Welfare, Government of India.
- Reference Manual for Oral Contraceptive Pills. March 2016. Family Planning Division Ministry of Health and Family Welfare, Government of India.
- ACOG Practice Bulletin No. 110: Non-contraceptive uses of hormonal contraceptives. Obstet Gynecol. 2010;115(1):206.
- Burnett M, Lemyre M. No. 345-Primary Dysmenorrhea Consensus Guideline. Journal of Obstetrics and Gynecology Canada, July 2017, Volume 39, Issue 7, Pages 585–595
- Wentzensen N, Poole EM, Trabert B, et al. Ovarian cancer risk factors by histologic subtype: An analysis from the Ovarian Cancer Cohort Consortium. Journal of Clinical Oncology 2016; 34(24):2888-2898
- Michels KA, Pfeiffer RM, Trabert B. Modification of the associations between duration of oral contraceptive use and ovarian, endometrial, breast, and colorectal cancers. JAMA Oncology 2018.
- Fernandez E, Chatenoud L, Franceschi S, Negri E. Oral contraceptives and colorectal cancer risk: a meta-analysis. Br J Cancer 2001; 84:722–7.
- Burkman RT. Review Oral contraceptives: current status. Clin Obstet Gynecol. 2001 Mar; 44(1):62-72
- Royal College of Obstetricians and Gynaecologists. GTG 33: Long Term Consequences of Polycystic Ovary Syndrome. Greentop Guideline No. 33. London: RCOG; 2007
- Drossaers-Bakker KW, Zwinderman AH, et al. Pregnancy and oral contraceptive use do not significantly influence outcome in long term rheumatoid arthritis. Ann Rheum Dis. 2002 May; 61(5):405-8.
Abstract Views: 303
PDF Views: 0